'Patients pay the tariff': Swiss pharma CEO warns of Trump's generic drug tariff threat
CNBC · C · trust 62/100
Sandoz CEO Richard Saynor warns steep U.S. tariffs on imported generic drugs could force manufacturers to raise prices or cut supply.
Read the original at CNBC →
Open in TruthVane →